Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Feb;80(2):109–116. doi: 10.1136/bjo.80.2.109

Risk factors for metastatic uveal melanoma after trans-scleral local resection.

B E Damato 1, J Paul 1, W S Foulds 1
PMCID: PMC505400  PMID: 8814739

Abstract

AIMS: This study reports the metastatic death rate after trans-scleral local resection of uveal melanoma and identifies relevant risk factors. METHODS: Local resection was performed in 332 patients (mean age 51 years), with follow up ranging to 20.9 years (median for living patients 33 months). The tumours had a mean largest basal diameter of 13.1 mm and mean thickness of 7.5 mm, with 135 containing epithelioid cells. Risk factors were identified by Cox analysis and metastatic rates demonstrated using Kaplan-Meier curves. RESULTS: There were 52 deaths from metastatic melanoma. The significant risk factors were (i) age more than 60 years at treatment (p = 0.001), (ii) mixed/epithelioid tumours (p = 0.003), (iii) superior location of mixed/epithelioid tumours (over and above (ii)) (p = 0.001), (iv) largest basal tumour diameter of 16 mm or more (p < 0.001), (v) lack of adjunctive radiotherapy (p = 0.031), (vi) secondary enucleation for bulky residual/recurrent tumour (p = 0.002), and (vii) secondary enucleation for small residual/recurrent tumour extraocularly (p = 0.019). Metastatic death was not significantly associated with (i) incomplete tumour excision (p = 0.163), and (ii) small residual/recurrent tumour treated by enucleation (p = 0.855). CONCLUSIONS: Survival diminished from 92% at 15 years if less than two risk factors were present to less than 30% in 3.5 years if more than three risk factors were present.

Full text

PDF
109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson D. H., Servodidio C. A., McCormick B., Fass D., Zang E. Changes in height of choroidal melanomas after plaque therapy. Br J Ophthalmol. 1990 Jun;74(6):359–362. doi: 10.1136/bjo.74.6.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Affeldt J. C., Minckler D. S., Azen S. P., Yeh L. Prognosis in uveal melanoma with extrascleral extension. Arch Ophthalmol. 1980 Nov;98(11):1975–1979. doi: 10.1001/archopht.1980.01020040827006. [DOI] [PubMed] [Google Scholar]
  3. Augsburger J. J., Gamel J. W., Lauritzen K., Brady L. W. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma. Am J Ophthalmol. 1990 May 15;109(5):585–592. doi: 10.1016/s0002-9394(14)70691-9. [DOI] [PubMed] [Google Scholar]
  4. Augsburger J. J., Gamel J. W., Shields J. A., Markoe A. M., Brady L. W. Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease. Ophthalmology. 1987 Sep;94(9):1173–1177. doi: 10.1016/s0161-6420(87)33310-x. [DOI] [PubMed] [Google Scholar]
  5. Char D. H., Castro J. R., Kroll S. M., Irvine A. R., Quivey J. M., Stone R. D. Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol. 1990 Feb;108(2):209–214. doi: 10.1001/archopht.1990.01070040061031. [DOI] [PubMed] [Google Scholar]
  6. Char D. H. Metastatic choroidal melanoma. Am J Ophthalmol. 1978 Jul;86(1):76–80. doi: 10.1016/0002-9394(78)90018-1. [DOI] [PubMed] [Google Scholar]
  7. Char D. H., Phillips T. L., Andejeski Y., Crawford J. B., Kroll S. Failure of preenucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol. 1988 Jul 15;106(1):21–26. doi: 10.1016/s0002-9394(14)76382-2. [DOI] [PubMed] [Google Scholar]
  8. Char D. H., Quivey J. M., Castro J. R., Kroll S., Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology. 1993 Oct;100(10):1547–1554. doi: 10.1016/s0161-6420(93)31446-6. [DOI] [PubMed] [Google Scholar]
  9. Coleman D. J., Silverman R. H., Rondeau M. J., Lizzi F. L., McLean I. W., Jakobiec F. A. Correlations of acoustic tissue typing of malignant melanoma and histopathologic features as a predictor of death. Am J Ophthalmol. 1990 Oct 15;110(4):380–388. doi: 10.1016/s0002-9394(14)77018-7. [DOI] [PubMed] [Google Scholar]
  10. Damato B. E., Paul J., Foulds W. S. Predictive factors of visual outcome after local resection of choroidal melanoma. Br J Ophthalmol. 1993 Oct;77(10):616–623. doi: 10.1136/bjo.77.10.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Damato B. E., Paul J., Foulds W. S. Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br J Ophthalmol. 1996 Feb;80(2):102–108. doi: 10.1136/bjo.80.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Diener-West M., Hawkins B. S., Markowitz J. A., Schachat A. P. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992 Feb;110(2):245–250. doi: 10.1001/archopht.1992.01080140101036. [DOI] [PubMed] [Google Scholar]
  13. Folberg R., Rummelt V., Parys-Van Ginderdeuren R., Hwang T., Woolson R. F., Pe'er J., Gruman L. M. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993 Sep;100(9):1389–1398. doi: 10.1016/s0161-6420(93)31470-3. [DOI] [PubMed] [Google Scholar]
  14. Foulds W. S., Damato B. E., Burton R. L. Local resection versus enucleation in the management of choroidal melanoma. Eye (Lond) 1987;1(Pt 6):676–679. doi: 10.1038/eye.1987.110. [DOI] [PubMed] [Google Scholar]
  15. Foulds W. S. The local excision of choroidal melanomata. Trans Ophthalmol Soc U K. 1973;93(0):343–346. [PubMed] [Google Scholar]
  16. Gamel J. W., McCurdy J. B., McLean I. W. A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci. 1992 May;33(6):1919–1922. [PubMed] [Google Scholar]
  17. Gamel J. W., McLean I. W., Greenberg R. A. Interval-by-interval Cox model analysis of 3680 cases of intraocular melanoma shows a decline in the prognostic value of size and cell type over time after tumor excision. Cancer. 1988 Feb 1;61(3):574–579. doi: 10.1002/1097-0142(19880201)61:3<574::aid-cncr2820610325>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  18. Glynn R. J., Seddon J. M., Gragoudas E. S., Egan K. M., Hart L. J. Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma. Ophthalmology. 1989 Oct;96(10):1566–1573. doi: 10.1016/s0161-6420(89)32685-6. [DOI] [PubMed] [Google Scholar]
  19. Gragoudas E. S., Egan K. M., Seddon J. M., Walsh S. M., Munzenrider J. E. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology. 1992 May;99(5):760–766. doi: 10.1016/s0161-6420(92)31900-1. [DOI] [PubMed] [Google Scholar]
  20. Gragoudas E. S., Seddon J. M., Egan K. M., Glynn R. J., Goitein M., Munzenrider J., Verhey L., Urie M., Koehler A. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 1988 Jul;95(7):992–999. doi: 10.1016/s0161-6420(88)33091-5. [DOI] [PubMed] [Google Scholar]
  21. Gragoudas E. S., Seddon J. M., Egan K., Glynn R., Munzenrider J., Austin-Seymour M., Goitein M., Verhey L., Urie M., Koehler A. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology. 1987 Apr;94(4):349–353. doi: 10.1016/s0161-6420(87)33456-6. [DOI] [PubMed] [Google Scholar]
  22. Jensen O. A. Malignent melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol (Copenh) 1970;48(6):1113–1128. [PubMed] [Google Scholar]
  23. Lommatzsch P. K. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience. Br J Ophthalmol. 1986 Nov;70(11):844–851. doi: 10.1136/bjo.70.11.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Manschot W. A., van Strik R. Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review. Int Ophthalmol. 1992 Mar;16(2):91–99. doi: 10.1007/BF00918938. [DOI] [PubMed] [Google Scholar]
  25. McLean M. J., Foster W. D., Zimmerman L. E. Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol. 1977 Jan;95(1):48–58. doi: 10.1001/archopht.1977.04450010050004. [DOI] [PubMed] [Google Scholar]
  26. Meecham W. J., Char D. H. DNA content abnormalities and prognosis in uveal melanoma. Arch Ophthalmol. 1986 Nov;104(11):1626–1629. doi: 10.1001/archopht.1986.01050230064033. [DOI] [PubMed] [Google Scholar]
  27. Packard R. B. Pattern of mortality in choroidal malignant melanoma. Br J Ophthalmol. 1980 Aug;64(8):565–575. doi: 10.1136/bjo.64.8.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Packer S., Stoller S., Lesser M. L., Mandel F. S., Finger P. T. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology. 1992 May;99(5):767–774. doi: 10.1016/s0161-6420(92)31899-8. [DOI] [PubMed] [Google Scholar]
  29. Peyman G. A., Juarez C. P., Diamond J. G., Raichand M. Ten years experience with eye wall resection for uveal malignant melanomas. Ophthalmology. 1984 Dec;91(12):1720–1725. doi: 10.1016/s0161-6420(84)34086-6. [DOI] [PubMed] [Google Scholar]
  30. Robertson D. M., Campbell R. J., Weaver D. T. Residual intrascleral and intraretinal melanoma: a concern with lamellar sclerouvectomy for uveal melanoma. Am J Ophthalmol. 1991 Nov 15;112(5):590–593. [PubMed] [Google Scholar]
  31. Seddon J. M., Albert D. M., Lavin P. T., Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983 Dec;101(12):1894–1899. doi: 10.1001/archopht.1983.01040020896012. [DOI] [PubMed] [Google Scholar]
  32. Seddon J. M., Gragoudas E. S., Egan K. M., Glynn R. J., Howard S., Fante R. G., Albert D. M. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 1990 Jun;97(6):769–777. doi: 10.1016/s0161-6420(90)32512-5. [DOI] [PubMed] [Google Scholar]
  33. Seddon J. M., Polivogianis L., Hsieh C. C., Albert D. M., Gamel J. W., Gragoudas E. S. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol. 1987 Jun;105(6):801–806. doi: 10.1001/archopht.1987.01060060087039. [DOI] [PubMed] [Google Scholar]
  34. Shammas H. F., Blodi F. C. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol. 1977 Jan;95(1):63–69. doi: 10.1001/archopht.1977.04450010065005. [DOI] [PubMed] [Google Scholar]
  35. Shields J. A., Shields C. L., Shah P., Sivalingam V. Partial lamellar sclerouvectomy for ciliary body and choroidal tumors. Ophthalmology. 1991 Jun;98(6):971–983. doi: 10.1016/s0161-6420(91)32194-8. [DOI] [PubMed] [Google Scholar]
  36. Vrabec T. R., Augsburger J. J., Gamel J. W., Brady L. W., Hernandez C., Woodleigh R. Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy. Ophthalmology. 1991 Jun;98(6):984–988. doi: 10.1016/s0161-6420(91)32193-6. [DOI] [PubMed] [Google Scholar]
  37. de la Cruz P. O., Jr, Specht C. S., McLean I. W. Lymphocytic infiltration in uveal malignant melanoma. Cancer. 1990 Jan 1;65(1):112–115. doi: 10.1002/1097-0142(19900101)65:1<112::aid-cncr2820650123>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES